SEC Comment Letter for CytoDyn Inc. (CYDY) (CIK 0001175680) (CYDY) — Mar 2, 2018
CytoDyn Inc. (CYDY) (CIK 0001175680)
Date: March 2, 2018 · CIK: 0001175680 · Accession: 0000000000-18-006670
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-223195
Letter
March 2, 2018 Nader Pourhassan, Ph.D. President and Chief Executive Officer CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver, Washington 98660 Re:CytoDyn Inc. Registration Statement on Form S-3 Filed February 23, 2018 File No. 333-223195 Dear Dr. Pourhassan: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Christine Westbrook at (202) 551-5019 with any questions. Division of Corporation Finance Office of Healthcare & Insurance cc: Steven M. Skolnick, Esq.
Show Raw Text
March 2, 2018
Nader Pourhassan, Ph.D.
President and Chief Executive Officer
CytoDyn Inc.
1111 Main Street, Suite 660
Vancouver, Washington 98660
Re:CytoDyn Inc.
Registration Statement on Form S-3
Filed February 23, 2018
File No. 333-223195
Dear Dr. Pourhassan:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Christine Westbrook at (202) 551-5019 with any questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Steven M. Skolnick, Esq.